The National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...

The experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...

"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...

India's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...

The Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...

A study showed that if the booster is the same as the first two doses, it boosts immunity well, but when the booster dose is different, the...

Poonawalla, ET's Business Leader Of the Year for 2021, was optimistic that final approvals for administering Covovax to children would come...

The Indian Council of Medical Research's NIE has proposed to conduct phase-2 safety and immunogenicity study specifically on people with co...

Christian Medical College (CMC), Vellore has said that it is conducting a study to test the efficacy of a booster dose on those who have re...

India is gearing up to tackle a possible third wave of the coronavirus pandemic as the Omicron variant of the virus, which is said to be mu...

"One could give an additional dose of the same vaccine but the results aren't as good as when the jabs are mixed," a senior government offi...

In an interview with ET, Dr Shahid Jameel warns that Covishield, which most Indians have got, will not be very effective as a third booster...

The Health Ministry told the Lok Sabha last week that the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the Nat...

In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at ...

In response to the chairman of the Serum Institute of India, Cyrus Poonawalla, emphasising the necessity for a third or booster dosage of C...

The ICMR study has indicated a 4.5-fold and 3.2-fold reduction in neutralising antibody levels against the Delta variant in those who were ...